New Developments in Precision Radiation Oncology & Radiogenomics Inaugural Symposium

Description

Precision Radiation Oncology Symposium
New Developments in Precision Radiation Oncology & Radiogenomics Inaugural Symposium

June 16, 2022, La Jolla, CA

Technological advances in radiotherapy, often driven by engineers, enable us to redefine how we detect, treat and monitor cancer. New developments in genomics provide a path for strategizing patient treatment. The purpose of this catalyst conference is to bring together experts in these areas to highlight current state of the art in cancer precision radiotherapy treatment and monitoring, which will highlight opportunities for collaborations and formulate strategies for addressing critical questions in adaptive precision driven innovation.

The meeting is primarily intended for radiation oncologists, medical physicists, medical oncologists, cancer bioinformatics researchers, as well as therapists, dosimetrists and researchers interested in developing new approaches in precision radiation therapy. The purpose of this catalyst conference is to bring together experts in these areas to highlight opportunities for collaborations and formulate strategies for addressing critical questions in adaptive precision driven innovation.

ORGANIZERS:
Ida Deichaite, PhD, Assistant Adjunct Professor, Radiation Medicine & Applied Sciences, Dir. Translational Programs, Moores Cancer Center, UC San Diego
Vitali Moiseenko, PhD, Professor, Radiation Medicine & Applied Sciences, UC San Diego
Kevin Moore, PhD, Professor & Deputy Division Director of Medical Physics, Radiation Medicine & Applied Sciences, UC San Diego
Arno J. Mundt, MD, FASTRO, FACRO, Chair, Radiation Medicine & Applied Sciences, UC San Diego
Xenia Ray, PhD, Assistant Professor, Radiation Medicine & Applied Sciences, UC San Diego

FURTHER INFORMATION: https://www.ucsdmccindustryrelations.com/new-developments-in-precision-radiation-oncology-and-radiogenomics/index.html